Gregory Daniel

Gregory Daniel is the Vice President, Head of Public Policy Innovation, Evidence and Engagement at Eli Lilly and Company, leading efforts in health policy and real-world evidence development. With a Doctor of Philosophy in Pharmaceutical Economics Policy and Outcomes from the University of Arizona, Gregory has previously held significant roles including Head of U.S. Healthcare Policy at Edwards Lifesciences and Fellow and Managing Director at The Brookings Institution. They possess extensive expertise in drug and medical device payment policy, value-based healthcare reforms, and leveraging real-world data to enhance healthcare outcomes. Gregory's commitment to advancing high-value innovation aims to meet patient needs while ensuring equitable access to treatment.